Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | 0.00% | -1.07% | -13.97% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.39M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.49
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.16% |
Latest transcript on Theriva Biologics, Inc.
1 week | -1.07% | ||
Current month | -8.07% | ||
1 month | -10.89% | ||
3 months | -24.96% | ||
6 months | -19.39% | ||
Current year | -13.97% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.37 | 0.00% | 34,554 |
24-05-20 | 0.37 | -0.19% | 36,519 |
24-05-17 | 0.3707 | -0.88% | 36,012 |
24-05-16 | 0.374 | +0.81% | 84,810 |
24-05-15 | 0.371 | -0.80% | 48,901 |
Delayed Quote Nyse, May 21, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.97% | 6.34M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- TOVX Stock